Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Bill Ounce who wrote (7651)	12/31/1997 2:08:00 PM
From: Scott H. Davis	Read Replies (2) \| Respond to of 14328

Bill, sorry, agreed. (I finally got the cash freed up and picked up some more TRIBY at 1.81, bringing my average to 2.26.) To All: remember earlier this fall when the concern was the resistance from the warrents at 3, and next year at 4 with the next gneration of warrents. At today's prices, getting stuck at 4 next fall actually sounds pretty good. Since the next report will bring a profitable year, therefore a positive set of balance sheet ratios (ROA, ROE, profit margin, price/cash flow etc.) added to the good current ratio and 114% projected EPS growth for next year, TRIBY should become attractive to a larger pool of investors. FYI Scott